The World Health Organization on has listed the Pfizer/BioNTech vaccine for emergency use, making it the first to receive such status since the pandemic began.
The WHO Emergency Use Listing opens the door for countries to fast-track their own regulatory approval to import and administer the Pfizer/BioNTech vaccine.
The objective of the procedure, the organization said, is to make medical products like vaccines available as rapidly as possible to address public health emergencies while adhering to stringent safety and quality checks.
The United Kingdom was the first Western country to authorize Pfizer/BioNTech's vaccine.
No comments:
Post a Comment